The trademark application LENZ was filed by HUMANIGEN, INC., a U.S. corporation (the "Applicant"). The application was published for oppositions on September 28, 2021, and it was registered by office on January 5, 2022 without any oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 1 with Chemical, biochemical and biotechnological preparations used in industry and science, namely, antibodies and fragments of antibodies for use in the manufacture of pharmaceutical preparations.
The mark was filed in class 5 with Pharmaceutical preparations and substances, namely, antibodies for the treatment of cancer, Immunotherapy-related toxicity, and COVID-19.